Chinese PE Firm HOPU, Bill Gates Invest In Long-Acting Drug Designer Lyndra

This Data Is Locked!

This area is available only to Subscribers.

American drug delivery system developer Lyndra Therapeutics has raised US$55 million in a series B round of financing from Chinese private equity firm HOPU Investments... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?